SCHEMBL4372097

SCHEMBL4372097

CN(C)NC(=O)C1(Cc2ccccc2)CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
ALOX15 P16050 1/20 0.47
ATM Q13315 1/20 0.47
OPRD1 P41143 1/20 0.46
OPRK1 P41145 1/20 0.46
STS P08842 1/20 0.46
TACR1 P25103 1/20 0.44
GPR119 Q8TDV5 3/20 0.44
JAK2 O60674 1/20 0.44
JAK1 P23458 1/20 0.44
HDAC1 Q13547 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
KDM4E B2RXH2 1/20 0.43
PKM P14618 1/20 0.43
MMP13 P45452 2/20 0.43
ADAM17 P78536 2/20 0.43
ACHE P22303 1/20 0.43
MMP2 P08253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4369133 0.87 TSHR (0.49) TSHRALOX15ATMOPRD1OPRK1
SCHEMBL12195183 0.85 KEAP1 (0.52) TSHRALOX15ATMOPRD1OPRK1
SCHEMBL1003119 0.85 OPRD1 (0.52) TSHRALOX15ATMOPRD1OPRK1
SCHEMBL1002715 0.84 PKM (0.55) TSHRALOX15ATMOPRD1OPRK1
SCHEMBL4832144 0.83 OPRD1 (0.51) TSHRALOX15ATMOPRD1OPRK1
SCHEMBL4832360 0.83 TSHR (0.46) TSHRALOX15ATMOPRD1OPRK1
SCHEMBL8512562 0.82 OPRD1 (0.53) TSHRALOX15ATMOPRD1OPRK1
SCHEMBL4832353 0.82 OPRD1 (0.46) TSHRALOX15ATMOPRD1OPRK1
SCHEMBL2465494 0.81 TP53 (0.52) TSHRALOX15ATMTACR1ACHE
SCHEMBL2375438 0.81 GPR119 (0.50) TSHRALOX15ATMOPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077941-B1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK AS (DK) 2009-08-12 EP disclosed
US-6303620-B1 USED FOR THERAPY OF MEDICAL DISORDERS RESULTING FROM A DEFICIENCY IN GROWTH HORMONE NOVO NORDISK A/S (DK) 2001-10-16 US disclosed